demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
IFN alpha
pegylated interferon-α2b Pandit Shashi Bhushan

0 studies excluded by filtering options 0